Digitisation | November 03, 2023
Can-Fite signs agreement with Collaborations Pharmaceuticals to develop anti-cancer drugs using AI
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
Sun Pharma will have exclusive rights to commercialise Nidlegy for indications of skin cancers in the territories of Europe, Australia and New Zealand. Philogen will complete pivotal clinical trials for the product in Europe
ZN-A-1041 was designed to be blood-brain-barrier-penetrant, and has the potential to treat or prevent the onset of brain metastases in patients with HER2-positive metastatic breast cancer
PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women with 98 percent accuracy
The combination will support clients in getting their end-to-end discovery and development programs delivered.
The new team members, Solenn Percelay and Noémie Spinelli, will support the organization’s commitment to excellence in humanized mouse model care and use
MoU signed between AIIA and University of Amrita Vishwa Vidhyapeetham for collaboration in the field of Research and Academics in Ayurveda
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
Subscribe To Our Newsletter & Stay Updated
